We used specific polyclonal antibodies against L-glutamate decarboxylase (GAD) to screen a mouse brain cDNA library that was constructed in the expression vector Agt11. We obtained 1.5 X 106 recombinant DNA clones in the mouse brain cDNA library. One of the clones was positively identified as a GAD clone on the basis of the following results: (i) the clone and its secondary and tertiary clones all reacted strongly with anti-GAD antibodies; (ii) the fusion protein obtained from AGAD-Y1089 showed good GAD enzyme activity as determined by both CO2 and y-aminobutyric acid methods. The GAD clone thus obtained contains GAD cDNA of "=2.6 kilobases that has one internal EcoRI site. After GAD cDNA was cut at the EcoRI site, two DNA fragments of about 1.6 and 1.0 kilobases were obtained at the 5' and 3' ends, respectively. The cDNA insert was found to be composed of 2632 base pairs, the translation initiation site was assigned to the methionine codon ATG, and the termination site was found to be TGA (positions 2216-2218). Furthermore, the coding region in 2169 base pairs was found to consist of 723 amino acids. The protein has a molecular weight of 83,207 and contains 83 strongly basic, 108 strongly acidic, 226 hydrophobic, and 221 polar amino acids with an isoelectric point of 5.355. The relationship of this GAD cDNA to other forms of GAD is discussed. y-Aminobutyric acid (GABA) has been established as a major neurotransmitter in the mammalian central nervous system from physiological, biochemical, pharmacological, and morphological studies (1-3). The rate-limiting step in GABA biosynthesis is the decarboxylation of L-glutamic acid by glutamate decarboxylase (GAD; L-glutamate 1-carboxylyase, EC 4.1.1.15) (1, 2) and hence GAD has been used as a specific marker for GABAergic neurons. Although much progress has been made in the identification of GABAergic neurons and their synaptic connectivities (for review, see ref.
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3), little is known with certainty regarding the regulation of GAD activity or the expression of the GAD gene. This is partially hampered by the existence of multiple forms of GAD, differing in molecular weight (4) , kinetic properties (5-7), and hydrophobic properties (7) , and the lack ofdetailed structural information about those forms of GAD. In this communication, we describe the cloning of the mouse brain GAD gene and the elucidation of a complete nucleotide sequence and the deduced amino acid sequence as a first step toward addressing these questions. 11 In addition, a comparison of similarities and differences between the mouse brain GAD gene presented in this communication and the feline GAD gene reported previously (8, 9 ) is included.
MATERIALS AND METHODS
Construction of cDNA Library. A mouse brain cDNA library was constructed in Agtll as described by Young and Davis (10) . Briefly, total RNA was extracted from mouse brain, and poly(A)+ RNA was prepared by oligo(dT)-cellulose chromatography (11) . Poly(A)+ RNA was reverse transcribed into double-stranded cDNA, which was inserted into the EcoRI site of Agt1l, yielding a library consisting of 1.5 x 106 independent clones.
Screening the cDNA Library with Antibody. About 1.5 x 106 clones were plated on 40 dishes of agar on a lawn of Escherichia coli Y1090 and the nitrocellulose filters presoaked with isopropyl f3-D-thiogalactoside were overlaid onto agar plates. The filter replicas of lysis plaques were first incubated with well-characterized primary antibodies, rabbit anti-purified rat brain GAD (12, 13) , followed by incubation with 1251-labeled secondary antibodies, goat anti-rabbit IgG, and were then processed for autoradiographic identification (primary screening). The GAD-positive clones identified in the primary screening were recloned and rescreened twice by the procedure described above (secondary and tertiary screening). The GAD-positive clone identified in the primary, secondary, and tertiary screenings was then used for fusion and sequencing studies. The specificity of anti-GAD antiserum was established from extensive immunochemical tests including immunoprecipitation, immunoblotting, immunodot, and immunoelectrophoresis tests (13) .
Expression of Fusion Protein in Bacteria. E. coli Y1089 was lysogenized with AGAD or nonrecombinant Agtll and induced with isopropyl f3-D-thiogalactoside. The fusion proteins thus obtained in the bacterial extract were then assayed for GAD activity by both CO2 and GABA methods as described (14) . Briefly, L-[U-'4C] glutamate was used as a substrate for the GAD assay and the reaction was terminated by the addition of 10 ,uM aminooxyacetic acid instead of 1.0 M H2SO4. The amounts of 14CO2 and [14C]GABA formed were determined by the hyamine base (15) and ion-exchange methods (14) , respectively. DNA Sequencing. The cDNA insert was excised by digestion with EcoRI and the two fragments obtained, 1.6 and 1.0 kilobases (kb), were subcloned into M13mpl8. Overlapping clones were obtained by exonuclease III deletion as described by Henikoff (16) . DNA was isolated from M13 plaques and sequenced by the dideoxynucleotide chain-termination method ofSanger et al. (17) using the M13 universal primer. Sequencing was done on one strand only, but from multiple clones, so each sequence segment has been confirmed several times. Software developed by Sequence. The nucleotide sequence and the deduced amino acid sequence for mouse brain GAD are shown in Fig. 1 . The cDNA insert was found to be composed of 2632 bp, the translational initiation site was assigned to the methionine codon ATG (positions 47-49), and the termination site was found to be TGA (positions 2216-2218). Furthermore, the coding region in 2169 bp was found to consist of 723 amino acids. The protein has a molecular weight of 83,207 and contains 83 strongly basic, 108 strongly acidic, 226 hydrophobic, and 221 polar amino acids with an isoelectric point of 5.355. The conformation of the protein deduced from the primary structure by the method of Garnier et al. (19) shows 51% helix, 15% ,(-sheet, 14% turn, and 20o coil. The segments of amino acid sequence that contain a-helix, (3-sheet, and turn are indicated in Fig. 1 . The amino acid composition of mouse brain GAD deduced from the nucleotide sequence is shown in Table 2 , together with those reported in the literature for GAD from human (20) , rat (21) , and feline brain (9) .
DISCUSSION
The identification of the GAD clone is based on two criteria: First, the clone reacts strongly with anti-GAD antiserum in (9) . This may be due to the difference in the cDNA library and the antibodies used in identification of GAD-positive clones. In the present study, we used well-characterized anti-GAD antiserum directed against purified rat brain GAD (12, 13) (7) reported the presence of a, 1, and 'y forms of GAD in porcine brain and four molecular forms of GAD in rat brain (6) that differ in their hydrophobic and kinetic properties. Wong et al. (4) reported that GAD in the developing brain differs from that of the adult brain in molecular weight as well as in immunological properties. Recently, Chang and Gottlieb (22) reported the presence of cytosolic and membrane-bound GAD in rat brain that showed some differences in NaDodSO4/PAGE. We have also reported the presence of two forms of GAD with different affinity toward the coenzyme pyridoxal phosphate (15) . Previously, we reported that mouse brain GAD has a molecular weight of 85,000 ± 2000, which is in good agreement with the molecular weight of 83,207 calculated from the amino acid sequence reported here. It is of interest that rat brain GAD is similar to mouse brain GAD in its isoelectric point (pI 5.4 vs. 5.355) (12) . Also, one of its subunits is of molecular weight similar to that of mouse brain GAD-80,000 ± 4000 (12) . Furthermore, from kinetic studies we have also shown (24, 25) that GAD preparations from both mouse and rat brain are highly sensitive to sulfhydryl agents [e.g., 5,5'-dithiobis(2-nitrobenzoic) acid and p-chloromercuribenzoic acid], mercapto compounds (e.g., 3-mercaptopropionic acid), dicarboxylic acids (e.g., glutaric acid), and carbonyl trapping agents (e.g., aminooxyacetic acid), suggesting that mouse brain GAD and rat brain GAD are probably closely related proteins. It is interesting to note that the composition of cysteine, lysine, arginine, and histidine in human (20) , rat (21) , and feline (9) GAD as reported in the literature is similar to that of the mouse brain reported here (see Table 2 ).
Another similarity among GAD from various species is the low content of aromatic amino acids-e.g., tryptophan, phenylalanine, and tyrosine-and the high content of acidic 8494 Neurobiology: Huang et al.
amino acids-e.g., glutamic and aspartic acids. The hydropathic character of mouse brain GAD as determined by the method of Kyte and Doolittle (23) indicates no strong hydrophobic region similar to feline GAD (9) and is compatible with the fact that this particular form of GAD is a soluble enzyme. Hence, it is reasonable to suggest that despite little homology in the sequence between mouse brain GAD and feline brain GAD, they probably have similar active sites and conformation. Future studies involving the use of site-specific mutagenesis and microsequencing (26) of purified GAD proteins should provide important information regarding the functional regions of the GAD molecule and the molecular nature of GAD isozymes.
